Post Classifieds

Israeli company creates possible cancer vaccine

On November 21, 2011

TEL AVIV, Israel—Scientists at Vaxil BioTherapeutics Ltd., a clinical-stage company in Israel, are developing an innovative cancer vaccine, according to the company database of the non-profit corporation Israel Life Science Industry. A recent article published on the website of United with Israel, a grassroots organization that focuses on Israel advocacy, reported that the vaccine is now in clinical trials at Hadassah University Medical Center in Jerusalem.

 Specifically, the vaccine is being assessed in the presence of multiple myeloma, a blood cancer. If successful, Vaxil's pioneering technology that developed the vaccine, VaxHit, could then be tried against all identified cancers and additionally examine the vaccine's effect on solid and non-solid tumors, according to United with Israel. The article also states that the vaccine, well on its way to success, is projected to be available for public use in six years, and is predicted to prevent about 90 percent of cancer recurrence. Vaxil's research currently focuses on creating novel synthetic T-cell therapeutic and preventative vaccines that act more like drugs than typical vaccines.

—Amanda Winn 

Get Top Stories Delivered Weekly

From Around the Web

More thejustice News Articles

Recent thejustice News Articles

Discuss This Article




Log In

or Create an account

Employers & Housing Providers

Employers can list job opportunities for students

Post a Job

Housing Providers can list available housing

Post Housing

Log In

Forgot your password?

Your new password has been sent to your email!

Logout Successful!

You just missed it! This listing has been filled.

Post your own housing listing on Uloop and have students reach out to you!

Upload An Image

Please select an image to upload
Note: must be in .png, .gif or .jpg format
Provide URL where image can be downloaded
Note: must be in .png, .gif or .jpg format